CompletedPhase 4

Randomized Controlled Trial to Compare Two Anti-scorpion Serums

120 participantsStarted 2008-08

Plain-language summary

The purpose of this study is to compare the efficiency and safety of the treatment against sting scorpion, using two serums, one elaborated by Birmex versus other commercial serum

Who can participate

Age range15 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Sting scorpion * Informed consent * Age 15-60 * Either sex * Resident in study area Exclusion Criteria: * Previous treatment with gammaglobulin * Blood transfusion at any stage of life * Sensitivity or intolerance to serums antiscorpion or horse products * Pregnancy * Some immunodeficiency

What they're measuring

Resolution of signs and symptoms of scorpion envenomation

Timeframe: after treatment (expected average of 12 hrs)

Trial details

NCT IDNCT00739440

SponsorLaboratorios de Biologicos y Reactivos de México, S.A. de C.V.

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-10

View on ClinicalTrials.gov More Scorpion Sting trials